Cardiol Therapeutics Inc. (NASDAQ: CRDL) Stock Information | RedChip

Cardiol Therapeutics Inc. (NASDAQ: CRDL)


$1.3300
+0.0500 ( -6.34% ) 306.9K

Cardiol Therapeutics Inc is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart diseases. The company's lead product candidate, CardiolRx, is a pharmaceutically manufactured oral cannabidiol formulation that is being clinically developed for use in heart diseases. Cardiol has received Investigational New Drug Application authorization from the United States Food and Drug Administration to conduct clinical studies to evaluate the efficacy and safety of CardiolRx in two diseases affecting the heart which are a Phase II multi-national trial, the ARCHER trial, in acute myocarditis; and a Phase II multi-center open-label pilot study in recurrent pericarditis.

Market Data


Open


$1.3300

Previous close


$1.2800

Volume


306.9K

Market cap


$101.19M

Day range


$1.2400 - $1.4190

52 week range


$0.8110 - $3.1200

SEC Filings


Form Type Description Pages Date
6-k Form 6-K 3 Jul 16, 2024
6-k Form 6-K 5 Jun 27, 2024
6-k Form 6-K 3 Jun 25, 2024
6-k Form 6-K 3 Jun 13, 2024
6-k Form 6-K 10 May 28, 2024
6-k Form 6-K 7 May 14, 2024
6-k Form 6-K 3 May 14, 2024
6-k Form 6-K 3 Apr 26, 2024
6-k Form 6-K 3 Apr 02, 2024
20-f Annual reports 116 Apr 01, 2024

Latest News